Optimization of Albuminuria Lowering Treatment by Crossover Rotation to Four Different Drug Classes

Medicine and Dentistry

• Albuminuria 100%
• Urinary System 100%
• Creatinine 100%
• Albumin 100%
• Telmisartan 25%
• Empagliflozin 25%
• Linagliptin 25%
• Baricitinib 25%
• Maturity Onset Diabetes of the Young 12%
• Insulin Dependent Diabetes Mellitus 12%
• Renal Protection 12%
• Renin Angiotensin Aldosterone System 12%
• Personalized Medicine 12%
• Renin-Angiotensin System Inhibitor 12%
• Therapy Resistance 12%

Keyphrases

• Drug Class 100%
• Albuminuria 100%
• Albumin-to-creatinine Ratio 100%
• Renin-angiotensin System Inhibitors 25%
• Telmisartan 25%
• Empagliflozin 25%
• Linagliptin 25%
• Baricitinib 25%
• Type 2 Diabetes Mellitus (T2DM) 12%
• Washout Period 12%
• Recommended Treatment 12%
• Personalized Therapy 12%
• Therapy Approaches 12%
• Kidney Protection 12%
• First Exposure 12%
• Therapy Resistance 12%
• Between-person Variation 12%
• Older Adults with Diabetes 12%
• Randomized Crossover 12%
• Treatment Period 12%
• Overcoming Resistance 12%

Pharmacology, Toxicology and Pharmaceutical Science

• Creatinine 100%
• Albuminuria 100%
• Albumin 100%
• Telmisartan 25%
• Empagliflozin 25%
• Linagliptin 25%
• Baricitinib 25%
• Insulin Dependent Diabetes Mellitus 12%
• Renin 12%
• Angiotensin 12%
• Renin-Angiotensin System Inhibitor 12%
• Therapy Resistance 12%
• Maturity Onset Diabetes of the Young 12%